Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Medicus Pharma Ltd ( (TSE:MDCX) ) has shared an update.
Medicus Pharma Ltd. has entered into a Standby Equity Purchase Agreement with YA II PN, LTD, allowing them to sell up to $15 million in shares over the next 36 months, contingent on SEC registration and other conditions. Additionally, the company has announced its intention to voluntarily delist from the TSX Venture Exchange, though its shares will continue to be traded on the NASDAQ, potentially affecting its market presence and investor base.
More about Medicus Pharma Ltd
Medicus Pharma Ltd. operates in the pharmaceutical industry, focusing on innovative healthcare solutions. The company is publicly traded on the NASDAQ Capital Market under the symbol ‘MDCX’.
YTD Price Performance: -2.53%
Average Trading Volume: 1,403
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: C$45.49M
See more insights into MDCX stock on TipRanks’ Stock Analysis page.
